Lilly launches Lormalzi for treatment of early symptomatic Alzheimer’s Disease in India EP News Bureau May 13, 2026 Eli Lilly and Company (India) announced the launch of Lormalzi (donanemab, 350 mg/20 mL IV vial) in India, following marketing…
